Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis increasing the risk of cerebrovascular complications

Lea Dib,Lada A Koneva,Andreas Edsfeldt,Yasemin-Xiomara Zurke,Jiangming Sun,Mihaela Nitulescu,Moustafa Attar,Esther Lutgens,Steffen Schmidt,Marie W Lindholm,Robin P Choudhury,Ismail Cassimjee,Regent Lee,Ashok Handa,Isabel Goncalves,Stephen N Sansom,Claudia Monaco
DOI: https://doi.org/10.1038/s44161-023-00295-x
2023-06-26
Abstract:The immune system is integral to cardiovascular health and disease. Targeting inflammation ameliorates adverse cardiovascular outcomes. Atherosclerosis, a major underlying cause of cardiovascular disease (CVD), is conceptualised as a lipid-driven inflammation where macrophages play a non-redundant role. However, evidence emerging so far from single cell atlases suggests a dichotomy between lipid associated and inflammatory macrophage states. Here, we present an inclusive reference atlas of human intraplaque immune cell communities. Combining scRNASeq of human surgical carotid endarterectomies in a discovery cohort with bulk RNASeq and immunohistochemistry in a validation cohort (the Carotid Plaque Imaging Project-CPIP), we reveal the existence of PLIN2hi/TREM1hi macrophages as a toll-like receptor-dependent inflammatory lipid-associated macrophage state linked to cerebrovascular events. Our study shifts the current paradigm of lipid-driven inflammation by providing biological evidence for a pathogenic macrophage transition to an inflammatory lipid-associated phenotype and for its targeting as a new treatment strategy for CVD.
What problem does this paper attempt to address?